SCHEMBL4602969

SCHEMBL4602969

O=c1[nH]c2nc[nH]c2c(=O)n1CCO

nearest known ligand 0.73

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
ADORA2B P29275 10/20 0.73
ADORA2A P29274 8/20 0.73
PDE4A P27815 8/20 0.73
PDE4B Q07343 8/20 0.73
PDE4C Q08493 8/20 0.73
PDE4D Q08499 8/20 0.73
ADORA3 P0DMS8 7/20 0.73
HPGD P15428 1/20 0.42
ADORA1 P30542 1/20 0.42
BLM P54132 1/20 0.42
PDE3A Q14432 1/20 0.42
HSD17B10 Q99714 1/20 0.42
ACHE P22303 1/20 0.41
GDA Q9Y2T3 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31081359 0.91 ADORA2B (0.74) ADORA2BADORA2APDE4APDE4BPDE4C
SCHEMBL9432924 0.88 ADORA2B (0.71) ADORA2BADORA2APDE4APDE4BPDE4C
SCHEMBL4423680 0.84 ADORA2B (1.00) ADORA2BADORA2APDE4APDE4BPDE4C
SCHEMBL5039468 0.82 ADORA2B (0.74) ADORA2BADORA2APDE4APDE4BPDE4C
SCHEMBL27395394 0.82 ADORA2B (1.00) ADORA2BADORA2APDE4APDE4BPDE4C
SCHEMBL6233166 0.82 ADORA2B (1.00) ADORA2BADORA2APDE4APDE4BPDE4C
SCHEMBL9750957 0.81 ADORA2B (0.69) ADORA2BADORA2APDE4APDE4BPDE4C
SCHEMBL27396492 0.81 ADORA2A (1.00) ADORA2BADORA2APDE4APDE4BPDE4C
SCHEMBL5515444 0.81 ADORA2A (0.71) ADORA2BADORA2APDE4APDE4BPDE4C
SCHEMBL380135 0.81 ADORA2A (1.00) ADORA2BADORA2APDE4APDE4BPDE4C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1912992-A1 XANTHINE DERIVATIVES AS SELECTIVE HM74A AGONISTS SmithKline Beecham Corporation (US) 2008-04-23 EP disclosed
WO-2007017262-A1 XANTHINE DERIVATIVES AS SELECTIVE HM74A AGONISTS SMITHKLINE BEECHAM CORPORATION (US) 2007-02-15 WO disclosed